Predicting the three-dimensional conformation of the cytoplasmic domain of FLT3 protein without mislaid residues is important to observe the structural variation on FLT3 protein upon mutations and its interaction with AML inhibitors. This evidence concerns the gene FLT3 and acute myeloid leukemia.